Search
01/12/2023
Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population
Almonacid-Sánchez C., García-Cosío B., Trisán-Alonso A., Callejas-González F.J., Cisneros C., Martínez-Moragón E., Plaza Moral V., Vera E., Soto-Campos J.G., Martínez-Rivera C., Alcazar-Navarrete B., Urrutia Landa I., García-Rivero J.L., Padilla Galo A., Álvarez-Gutierrez F., Ramos-González J., Carretero-Gracia J.Á., Lluch I., Puente L., Andujar-Espinosa R., Pérez-de-Llano L.. Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(12)DOI:10.1016/j.arbres.2023.08.017. PMID:37865605. IF:8.700(Q1/1D).
01/12/2023
Facial nerve palsy following parotid gland surgery: A machine learning prediction outcome approach
Chiesa-Estomba C.M., González-García J.A., Larruscain E., Sistiaga Suarez J.A., Quer M., León X., Martínez-Ruiz de Apodaca P., López-Mollá C., Mayo-Yanez M., Medela A.. Facial nerve palsy following parotid gland surgery: A machine learning prediction outcome approach. WORLD JOURNAL OF OTORHINOLARYNGOLOGY-HEAD & NECK SURGERY. 2023; 9(4)DOI:10.1002/wjo2.94. PMID:38059137. IF:(Q/D).
01/12/2023
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study
Bastos-Oreiro M., Gutierrez A., Iacoboni G., López Corral L., Reguera J.L., Abrisqueta P., Delgado J., Terol M.J., Hernani R., Martínez N., Ortíz V., Bailen R., Gomez-Centurión I., Caballero A., Sanz J., Guerra Domínguez L., Luzardo H., Mussetti A., Jiménez-Ubieto A., Sancho J.M., Sureda A., Pérez A., Barba P., Kwon M., Martín García-Sancho A.. Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study. Transplantation And Cellular Therapy. 2023; 29(12)DOI:10.1016/j.jtct.2023.08.026. PMID:37659694. IF:3.600(Q1/3D).
01/12/2023
Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients
Arqueros, C, Salazar, J, Gallardo, A, Andrés, M, Tibau, A, Bell, OL, Artigas, A, Lasa, A, Cajal, T, Lerma, E, Barnadas, A. Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients. Biomedicines. 2023; 11(12)DOI:10.3390/biomedicines11123231. PMID:38137452. IF:3.900(Q1/3D).